Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation. | Front Pharmacol | 2022 | 36642989 | PubTator, text mining | PubMed |
| ERK phosphorylation disrupts the intramolecular interaction of capicua to promote cytoplasmic translocation of capicua and tumor growth. | Front Mol Biosci | 2022 | 36619173 | PubTator, text mining | PubMed |
| Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 | 36612014 | PubTator, text mining | PubMed |
| Multiparametric magnetic resonance imaging-derived deep learning network to determine ferroptosis-related gene signatures in gliomas. | Front Neurosci | 2022 | 36605558 | PubTator, text mining | PubMed |
| A case report of CIC-DUX4 fusion-positive sarcoma in the pelvic cavity with targeted next-generation sequencing results. | Front Oncol | 2022 | 36591446 | PubTator, text mining | PubMed |
| SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer. | BMC Cancer | 2022 | 36585688 | PubTator, text mining | PubMed |
| Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer. | J Pers Med | 2022 | 36579559 | PubTator, text mining | PubMed |
| The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells. | NPJ Precis Oncol | 2022 | 36575215 | PubTator, text mining | PubMed |
| Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration. | Front Immunol | 2022 | 36569844 | PubTator, text mining | PubMed |
| Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. | J Pers Med | 2022 | 36556227 | PubTator, text mining | PubMed |
| Primary Breast Angiosarcoma: Comparative Transcriptome Analysis. | Int J Mol Sci | 2022 | 36555675 | PubTator, text mining | PubMed |
| Identification of the Transcriptional Regulatory Role of RUNX2 by Network Analysis in Lung Cancer Cells. | Biomedicines | 2022 | 36551878 | PubTator, text mining | PubMed |
| New Insights into the Phenotype Switching of Melanoma. | Cancers (Basel) | 2022 | 36551603 | PubTator, text mining | PubMed |
| Identification of prognostic values of the transcription factor-CpG-gene triplets in lung adenocarcinoma: A narrative review. | Medicine (Baltimore) | 2022 | 36550923 | PubTator, text mining | PubMed |
| Expanding the spectrum of "mesenchymal" tumors of the central nervous system. | Pathologica | 2022 | 36534424 | PubTator, text mining | PubMed |
| New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2. | Genome Biol | 2022 | 36494864 | PubTator, text mining | PubMed |
| TBX2 specifies and maintains inner hair and supporting cell fate in the Organ of Corti. | Nat Commun | 2022 | 36494345 | PubTator, text mining | PubMed |
| Screening of Hub Genes in Hepatocellular Carcinoma Based on Network Analysis and Machine Learning. | Comput Math Methods Med | 2022 | 36479313 | PubTator, text mining | PubMed |
| Arginine methylation of BRD4 by PRMT2/4 governs transcription and DNA repair. | Sci Adv | 2022 | 36475791 | PubTator, text mining | PubMed |
| A joint transcriptional regulatory network and protein activity inference analysis identifies clinically associated master regulators for biliary atresia. | Front Pediatr | 2022 | 36440333 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=21